Cranor, C.W., Bunting, B.A., Christensen, D.B. (2003) The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes care Program. Journal of the American Pharmaceutical Association, 43, 173-184.
https://doi.org/10.1331/108658003321480713

has been cited by the following article:

• TITLE: Effectiveness of Clinical Pharmacist Directed-Diabetes Management

  AUTHORS: Neha Farheen Tabassum, N. Himanandini, Manaal Fathima, M. Sankeerthna, Nikhil Kumar Vanjari, Siva Subrahmanyam Bandaru

  KEYWORDS: Diabetes Mellitus, Clinical Pharmacist, Glycated Hemoglobin, Fasting Plasma Glucose, Post-Prandial Blood Glucose, Diabetes Care and Management

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.9 No.3, August 22, 2019

  ABSTRACT: Objective: The main aim of the study is predominately utilizing clinical pharmacist in the provision of continuing diabetic education programs to emphasize and re-emphasize the importance of risk factors, prevention, adherence to medication and behavioral changes to prevent recurrences of the disease, their progression, and ultimately minimize hospitalization. Specific goals are to improve clinical outcomes for patients with diabetes—to maintain optimal plasma glucose concentrations Fasting, Postprandial Plasma Glucose, and Glycated Hemoglobin. Study design: A prospective interventional study in the Outpatient General Medicine Department, for a period of six months from October 2018 to March 2019. Results: HbA1c levels were reduced from baseline by −1.107 ± 0.8634, Fasting Plasma Glucose levels and Postprandial blood glucose levels were reduced from baseline by −24.2218 ± 5.70352 and −30.1891 ± 1.40592 respectively. Conclusion: A trained clinical pharmacist by providing diabetes education and care can significantly reduce hyperglycemia, thereby improving the quality of life in diabetes patients and ultimately reducing health care costs associated with these morbidities.